Your browser doesn't support javascript.
loading
A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients.
Nuttall, Gregory A; Smith, Mark M; Smith, Bradford B; Christensen, Jon M; Santrach, Paula J; Schaff, Hartzell V.
Afiliação
  • Nuttall GA; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Smith MM; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Smith BB; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Christensen JM; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Santrach PJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Schaff HV; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.
Ann Thorac Cardiovasc Surg ; 28(3): 204-213, 2022 Jun 20.
Article em En | MEDLINE | ID: mdl-34937821

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina / Procedimentos Cirúrgicos Cardíacos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina / Procedimentos Cirúrgicos Cardíacos Idioma: En Ano de publicação: 2022 Tipo de documento: Article